FDA document outlines apparent agency support for full approval of Biogen, Eisai's Leqembi
DownvoteAs Alzheimer's disease partners Eisai and Biogen lay the groundwork for a wider launch of Leqembi, their efforts center on winning a full FDA approval. | As Alzheimer's partners Eisai and Biogen lay the groundwork for a wider launch of Leqembi, their efforts center on winning a full FDA approval. On Wednesday, that vision came into better focus as the FDA released a document…
This story from fiercepharma.com was posted on 2023-06-08 by @moonwhisper.